{"id":"W4213176775","doi":"10.1016/j.jbo.2022.100416","title":"Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval","year":2022,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Amgen; National Multiple Sclerosis Society Michigan Chapter","keywords":"Denosumab; Medicine; Discontinuation; Multiple myeloma; Zoledronic acid; Dosing; Oncology; Osteonecrosis of the jaw; Bisphosphonate; Pathologic fracture; Internal medicine; Surgery; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007807703,0.0004102585,0.0006149925,0.0004705855,0.0005651728,0.002043645,0.0006229146,0.001554275,0.006284974],"category_scores_gemma":[0.007293136,0.0001797133,0.0008626806,0.0007474618,0.0006436193,0.001473939,0.0008629066,0.003899361,0.002425949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009443662,"about_ca_system_score_gemma":0.001120463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001168129,"about_ca_topic_score_gemma":0.002221062,"domain_scores_codex":[0.9979919,0.0006366091,0.0002243606,0.0002187532,0.0006270838,0.0003012151],"domain_scores_gemma":[0.9970629,0.0009727924,0.0004828679,0.0001626196,0.0006110802,0.0007077829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001870455,0.00092561,0.008932326,0.001108518,0.000248097,0.001710986,0.0008974092,0.0005420784,0.004152907,0.008225839,0.1026136,0.8687722],"study_design_scores_gemma":[0.0008078038,0.002809174,0.01145223,0.001029301,0.0001571148,0.004309561,0.0002244523,0.0002270656,0.001831421,0.001422418,0.975697,0.00003231375],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1039323,0.6495483,0.01138254,0.08511931,0.007074211,0.0005373803,0.001201052,0.0005094889,0.1406955],"genre_scores_gemma":[0.4899521,0.3486106,0.007339866,0.09485374,0.008300503,0.0003837026,0.003543037,0.0003657041,0.04665081],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007807703,"threshold_uncertainty_score":0.04129159,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06026342711057341,"score_gpt":0.4142754096047931,"score_spread":0.3540119824942197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}